The Drug Regulatory Authority of Pakistan (DRAP) has introduced a new regulation requiring all pharmaceutical products to carry barcodes and unique serial numbers. This move aims to improve the traceability of medicines throughout the supply chain, ensuring authenticity and patient safety. By implementing these measures, DRAP seeks to combat the growing issue of counterfeit drugs in the market, which pose significant health risks.
Notably, the introduction of barcodes and unique serial numbers will facilitate better inventory management and monitoring by manufacturers, distributors, and regulatory bodies. This system allows for real-time tracking and verification, reducing the chances of fraudulent products reaching consumers. The regulation aligns Pakistan with international standards for pharmaceutical quality control, enhancing the credibility of its healthcare sector.
In a significant development for public health, this mandate is expected to increase consumer confidence in medicine safety and efficacy. It also supports law enforcement efforts to crack down on illegal drug distribution networks. As the pharmaceutical industry adapts to these requirements, patients can anticipate improved access to genuine medicines, contributing to overall health outcomes in the country.
Leave an opinion